Neutrophil elastase-mediated lung disease

COPD: Journal of Chronic Obstructive Pulmonary Disease

Volumn 10, Issue S1, 2013, Pages 60-63

  Sandhaus, Robert A ^a   Turino, Gerard ^b  

^a DEPARTMENT OF MEDICINE   (United States)

^b College of Physicians and Surgeons ^*  (United States)

Author keywords

Alpha 1 antitrypsin deficiency; Emphysema; Neutrophil elastase

Indexed keywords

ALPHA 1 ANTITRYPSIN; LEUKOCYTE ELASTASE; LEUKOCYTE ELASTASE INHIBITOR;

ALPHA 1 ANTITRYPSIN DEFICIENCY; CELL MIGRATION; DRUG EFFECT; HUMAN; INFLAMMATION; LUNG DISEASE; NEUTROPHIL; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEGRADATION; REVIEW; RISK ASSESSMENT;

ALPHA 1-ANTITRYPSIN; ALPHA 1-ANTITRYPSIN DEFICIENCY; HUMANS; LEUKOCYTE ELASTASE; PULMONARY EMPHYSEMA; SERINE PROTEINASE INHIBITORS;

EID: 84875670639     PISSN: 15412555     EISSN: 15412563     Source Type: Journal    
DOI: 10.3109/15412555.2013.764403     Document Type: Review

References (32)

1. Turino GM. The origins of a concept: the protease-antiprotease imbalance hypothesis. Chest 2002; 122(3):1058-1060. PubMed PMID: 12226052.
2. Cowdrey CR, Kleinerman J, Wright GW. Photographic reconstruction of a three-dimensional model of the lung, with special reference to centrilobular emphysema. Am Rev Respir Dis. 1963; 87:239-244. PubMed PMID: 14023527.
3. Gross P, Babyak MA, Tolker E, Kaschak M. Enzymatically produced pulmonary emphysema; a preliminary report. J Occup Med 1964; 6:481-484. Epub 1964/12/01. PubMed PMID: 14241128.
4. Snider GL, Hayes JA, Franzblau C, Kagan HM, Stone PS, Korthy AL. Relationship between elastolytic acitivity and experimental emphysema-induced properties of papain preparations. Am Rev Respir Dis 1974; 110(3):254-262. PubMed PMID: 4415535.
5. Hayes JA, Korthy A, Snider GL. The pathology of elastaseinduced panacinar emphysema in hamsters. J Pathol 1975; 117(1):1-14. doi: 10.1002/path. 1711170102. PubMed PMID: 1195057.
6. Turino GM. Proteolytic mechanisms and pulmonary emphysema. Bull Physiopathol Respir 1971; 7(4):719-727. PubMed PMID: 4107042.
7. Chrzanowski PJ, Turino GM. Experimental emphysema: concepts and questions. Bull Eur Physiopathol Respir 1977; 13(4):471-477. PubMed PMID: 334287.
8. Turino GM, Senior RM, Garg BD, Keller S, Levi MM, Mandl I. Serum elastase inhibitor deficiency and alpha-1 antitrypsin deficiency in patients with obstructive emphysema. Science 1969; 165(3894):709-711. PubMed PMID: 5793975.
9. Janoff A, Scherer J. Mediators of inflammation in leukocyte lysosomes. IX. Elastinolytic activity in granules of human polymorphonuclear leukocytes. J Exp Med 1968; 128(5):1137- 1155. PubMed PMID: 5303065; PubMed Central PMCID: PMC2138566.
10. Senior RM, Tegner H, Kuhn C, Ohlsson K, Starcher BC, Pierce JA. The induction of pulmonary emphysema with human leukocyte elastase. Am Rev Respir Dis 1977; 116(3):469-75. PubMed PMID: 900634.
11. Sandhaus RA, Janoff A. Elastase-induced emphysema: retention of instilled proteinase in the rat. Am Rev Respir Dis 1982; 126(5):914-920. Epub 1982/11/01. PubMed PMID: 6756234.
12. Stone PJ, Pereira W, Jr., Biles D, Snider GL, Kagan HM, Franzblau C. Studies on the fate of pancreatic elastase in the hamster lung: 14C-guanidinated elastase. Am Rev Respir Dis 1977; 116(1):49-56. PubMed PMID: 879599.
13. Senior RM, Bielefeld DR, Starcher BC. Comparison of the elastolytic effects of human leukocyte elastase and porcine pancreatic elastase. Adv Exp Med Biol 1977; 79:249-261. PubMed PMID: 868639
14. Janoff A. Inhibition of human granulocyte elastase by serum alpha-1 antitrypsin. Am Rev Respir Dis 1972; 105(1):121-122. PubMed PMID: 5007608.
15. Blackwood RA, Cerreta JM, Mandl I, Turino GM. Alpha-1 antitrypsin deficiency and increased susceptibility to elastase-induced experimental emphysema in a rat model. Am Rev Respir Dis 1979; 120(6):1375-1379. PubMed PMID: 316297.
16. Janoff A, Carp H. Possible mechanisms of emphysema in smokers: cigarette smoke condensate suppresses protease inhibition in vitro. Am Rev Respir Dis 1977; 116(1):65-72. Epub 1977/07/01. PubMed PMID: 301725.
17. Carp H, Janoff A. Possible mechanisms of emphysema in smokers. In vitro suppression of serum elastase-inhibitory capacity by fresh cigarette smoke and its prevention by antioxidants. Am Rev Respir Dis 1978; 118(3):617-621. PubMed PMID: 101105.
18. Janoff A, Carp H, Lee DK, Drew RT. Cigarette smoke inhalation decreases alpha-1 antitrypsin activity in rat lung. Science 1979; 206(4424):1313-1314. PubMed PMID: 316187.
19. Johnson D, Travis J. The oxidative inactivation of human alpha-1 proteinase inhibitor. Further evidence for methionine at the reactive center. J Biol Chem 1979; 254(10):4022-4026. PubMed PMID: 312289.
20. Janoff A. Elastases and emphysema. Current assessment of the protease-antiprotease hypothesis. Am Rev Respir Dis 1985; 132(2):417-433. Epub 1985/08/01. PubMed PMID: 3896082.
21. Rouhani F, Paone G, Smith NK, Krein P, Barnes P, Brantly ML. Lung neutrophil burden correlates with increased proinfl ammatory cytokines and decreased lung function in individuals with alpha(1)-antitrypsin deficiency. Chest 2000; 117(5 Suppl 1):250S-251S. PubMed PMID: 0010843938.
22. Survival and FEV1 decline in individuals with severe deficiency of alpha-1 antitrypsin. The Alpha-1-Antitrypsin Deficiency Registry Study Group. Am J Respir Crit Care Med 1998; 158(1):49-59. PubMed PMID: 9655706.
23. Dirksen A, Dijkman JH, Madsen F, Stoel B, Hutchison DC, Ulrik CS, et al. A randomized clinical trial of alpha-1 antitrypsin augmentation therapy. Am J Respir Crit Care Med 1999; 160(5 Pt 1):1468-1472. PubMed PMID: 10556107.
24. Stockley RA, Parr DG, Piitulainen E, Stolk J, Stoel BC, Dirksen A. Therapeutic efficacy of alpha-1 antitrypsin augmentation therapy on the loss of lung tissue: an integrated analysis of 2 randomised clinical trials using computed tomography densitometry. Respir Res 2010; 11:136. Epub 2010/10/06. doi: 10.1186/1465-9921-11-136. PubMed PMID: 20920370; PubMed Central PMCID: PMC2964614.
25. Seersholm N, Wencker M, Banik N, Viskum K, Dirksen A, Kok-Jensen A, et al. Does alpha-1 antitrypsin augmentation therapy slow the annual decline in FEV1 in patients with severe hereditary alpha1-antitrypsin deficiency? Wissenschaftliche Arbeitsgemeinschaft zur Therapie von Lungenerkrankungen (WATL) alpha1-AT study group. Eur Respir J 1997; 10(10):2260-2263. PubMed PMID: 9387950.
26. Hautamaki RD, Kobayashi DK, Senior RM, Shapiro SD. Requirement for macrophage elastase for cigarette smokeinduced emphysema in mice. Science 1997; 277(5334):2002- 2004. PubMed PMID: 9302297.
27. Chan ED, Kaminska AM, Gill W, Chmura K, Feldman NE, Bai X, et al. Alpha-1 antitrypsin (AAT) anomalies are associated with lung disease due to rapidly growing mycobacteria and AAT inhibits Mycobacterium abscessus infection of macrophages. Scand J Infect Dis 2007; 39(8):690-696. doi: 10.1080/ 00365540701225744. PubMed PMID: 17654345.
28. Flotte TR, Trapnell BC, Humphries M, Carey B, Calcedo R, Rouhani F, et al. Phase 2 clinical trial of a recombinant adenoassociated viral vector expressing alpha-1 antitrypsin: interim results. Hum Gene Ther 2011; 22(10):1239-1247. doi: 10.1089/hum.2011.053. PubMed PMID: 21609134; PubMed Central PMCID: PMC3205788.
29. Flotte TR, Brantly ML, Spencer LT, Byrne BJ, Spencer CT, Baker DJ, et al. Phase I trial of intramuscular injection of a recombinant adeno-associated virus alpha-1 antitrypsin (rAAV2-CBhAAT) gene vector to AAT-deficient adults. Hum Gene Ther 2004; 15(1):93-128. doi: 10.1089/10430340460732490. PubMed PMID: 14965381.
30. Spencer LT, Paone G, Krein PM, Rouhani FN, Rivera-Nieves J, Brantly ML. Role of human neutrophil peptides in lung inflammation associated with alpha-1 antitrypsin deficiency. Am J Physiol Lung Cell Mol Physiol 2004; 286(3):L514-520. Epub 2003/11/05. doi: 10.1152/ajplung.00099.2003 00099.2003 [pii]. PubMed PMID: 14594730.
31. Senior RM, Griffin GL, Mecham RP. Chemotactic activity of elastin-derived peptides. J Clin Invest 1980; 66(4):859-862. doi: 10.1172/JCI109926. PubMed PMID: 6903189; PubMed Central PMCID: PMC371663
32. Wewers M, Crystal R. Alpha-1 antitrypsin augmentation therapy. 2013 COPD, 10:S1; 64-67.